| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.059 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |